Pharmaceutical Industry Articles & Reports - Page 9

A comprehensive guide to decentralized clinical trials (DCTs). Review hybrid trial technologies, compare software platforms, and explore implementation steps.

Examine how AI and real-time quality monitoring ensure GMP compliance in pharmaceutical manufacturing. Review machine learning frameworks and FDA guidelines.

A guide to FDA regulatory pathways for AI/ML SaMD. Compare 510(k), De Novo, and PMA submission requirements for artificial intelligence medical devices.

Examine how agentic AI automates pharmaceutical regulatory documents like CSRs, NDAs, and eCTD workflows while managing compliance and validation risks.

Learn how to quantify AI ROI in pharmacovigilance. This guide analyzes cost drivers, payback periods, and metrics for automating PV case processing workflows.

Learn why 95% of pharma AI pilots fail to reach production. This guide explains PoC failure causes, data integration challenges, and strategies for scaling.

Explore pharma AI change management and organizational readiness strategies. Understand how life science companies build AI literacy to address skills gaps.

Examine how digital twins in clinical trials function as virtual control arms. This report reviews FDA guidance, AI models, and implementation requirements.

Review the FDA's 7-step AI credibility assessment framework. Understand how to validate and document AI models for regulatory drug development submissions.

Examine the technical and operational factors of CDMS replacement. Compare legacy SAS systems with modern cloud EDC platforms in clinical data management.

Learn how agentic AI in pharma transitions from pilot stages to production. Explore autonomous multi-agent systems, clinical use cases, and regulatory impacts.

Learn how Biobank LIMS software manages specimen tracking, chain-of-custody, and complex data architecture. Compare leading BIMS solutions for biorepositories.

Review how modern CTMS dashboards track clinical trial KPIs. This guide explains operational metrics for enrollment, site performance, and data management.

Examine why most pharma AI pilots fail to reach production. This report analyzes data fragmentation, governance issues, and building scalable data foundations.

A 2026 evaluation framework for selecting pharma AI consulting firms. Review vendor criteria including regulatory compliance, data governance, and AI expertise.

Explore the 2026 FDA-EMA 10 Guiding Principles of Good AI Practice in drug development. Learn about regulatory frameworks, compliance, and AI risk management.

Review a detailed 2026 commercial LIMS comparison. This report analyzes LabWare, STARLIMS, LabVantage, Sapio, and LabWizard features and deployment models.

Review how pharma data engineering workshops train teams in Databricks and AI. Examine Lakehouse architecture, GxP compliance, and workforce skills development.

Analyze IT integration in biopharma M&A. This report explains strategies for consolidating GxP systems, ensuring compliance, and capturing cost synergies.

An analysis of AI governance in pharmacovigilance, detailing how the EU AI Act and GxP regulations impact drug safety platforms like Oracle Argus and Veeva.

Compare open-source MES and ERP solutions for pharmaceutical manufacturing. Analyze ERPNext, Odoo, and others for GMP, 21 CFR Part 11, and Annex 11 compliance.

Review commercial software solutions for GMP-compliant manufacturing. Compare pharma MES, electronic batch records (eBR), and ERP systems for 21 CFR compliance.

Learn frameworks for GxP-safe AI. Covers RAG, audit trails, and data isolation to ensure 21 CFR Part 11 and Annex 11 compliance in pharma.

Review 10 years of FDA 483 patterns and EMA reports. Learn the four core inspection question clusters and the specific evidence required for compliance.